Welcome to our dedicated page for Xerox Holdings SEC filings (Ticker: XRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Xerox Holdings Corporation (XRX) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, as filed with the U.S. Securities and Exchange Commission. Xerox is incorporated in New York and its common stock trades on the Nasdaq Global Select Market under the symbol XRX. Through its filings, the company reports on financial performance, corporate governance, executive compensation, financing arrangements, and material corporate events.
Investors tracking XRX can review Form 8‑K current reports that detail significant developments such as the completion of the Lexmark acquisition, new debt and note issuances, warrant agreements, and leadership changes. Recent 8‑K filings describe the July 1, 2025 acquisition of Lexmark, related financing transactions including senior notes and term loans, and subsequent integration and synergy plans. Other 8‑K reports cover executive appointments and departures, including changes in the Chief Financial Officer role and President and Chief Operating Officer position, as well as earnings releases for quarterly results.
In addition to 8‑K filings, users can expect access to annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which typically contain segment information for Print and Other and IT Solutions, risk factor discussions, and management’s analysis of results. Proxy materials and other governance-related filings provide further detail on board structure and executive compensation programs, including severance and change‑in‑control arrangements referenced in current reports.
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping users quickly understand the implications of complex disclosures such as financing structures, acquisition terms, or executive compensation agreements. Real-time updates from EDGAR ensure that new XRX filings, including Form 4 insider transaction reports when available, are added promptly so investors can monitor regulatory activity alongside market data and news.
Xerox Holdings Corp. received a Schedule 13G reporting that The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC beneficially own 9,727,573.90 shares of Xerox common stock, representing 7.7% of the outstanding class as of 12/31/2025.
The filing shows no sole voting or dispositive power, but shared voting power over 9,727,095.90 shares and shared dispositive power over 9,727,205.90 shares. The reporting parties certify the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Xerox.
Xerox Holdings Corporation is registering up to $750,000,000 of common stock to be issued upon exercise of newly distributed warrants. The company has completed a pro rata distribution of warrants to holders of its common stock, 3.75% Convertible Senior Notes due 2030, and Series A Convertible Perpetual Voting Preferred Stock as of February 9, 2026, at a rate of one warrant for every two common shares.
Each warrant allows the holder to buy one Xerox share at an exercise price of $8.00 per share, payable in cash or, for a period, by delivering specified Xerox debt securities. The warrants are expected to trade on Nasdaq under the symbol XRXDW and will generally expire on February 11, 2028, with provisions for early expiration and for ending the debt-settlement option if the share price meets volume-weighted average price conditions. A legal opinion also covers issuance of shares upon exercise of 77,271,234 warrants and up to 5,192,626 additional shares to B. Dyson Capital Advisors or its affiliates as compensation for advisory services related to the distribution.
Xerox Holdings Corporation is registering up to 82,463,860 shares of common stock tied to a new warrant distribution and advisor compensation. This includes 77,271,234 Warrant Shares issuable upon exercise of transferable warrants and 5,192,626 Advisor Shares to be issued as fees to a financial advisor.
One warrant was distributed for every two common shares held on February 9, 2026, with additional warrants passed through to certain note and preferred holders. Each warrant allows purchase of one share at a $8.00 exercise price in cash or by surrendering specified outstanding notes, potentially raising about $615 million in cash if fully exercised or reducing debt if notes are used. If all Warrant Shares and Advisor Shares are issued, common shares outstanding would rise to 211,061,812, an increase of about 64%, and the warrants may expire early if price conditions are met.
Xerox Holdings Corporation officer Colon Flor reported equity compensation activity. On February 4, 2026, Flor acquired 2,456 shares of common stock at $0 per share after the Compensation Committee determined performance conditions were met for performance share units granted on January 18, 2023.
Of these vested performance share units, 1,016 shares were withheld and disposed of at $2.29 per share to cover taxes. After these transactions, Flor directly owned 17,233 shares of Xerox common stock.
Xerox Holdings Corp. reported an insider equity award for Chief Revenue Officer Jacques-Edouard Gueden. On February 4, 2026, he acquired 12,499 shares of common stock at $0 upon vesting of performance share units granted on January 18, 2023.
Of these vested units, 7,000 shares were withheld and disposed of at $2.29 per share to cover taxes, leaving Gueden with 79,152 directly owned Xerox shares after the transactions.
Steven John Bandrowczak, CEO and director of Xerox Holdings Corp., reported equity-based compensation activity in company stock. On February 4, 2026, he acquired 66,960 shares of common stock at $0 per share after performance share units granted in January 2023 vested based on Compensation Committee determinations.
Of these vested shares, 20,986 shares were withheld and disposed of at $2.29 per share to cover taxes. Following these transactions, he held 499,141 shares of Xerox common stock directly.
Xerox Holdings Corporation and Xerox Corporation filed an 8-K stating they issued a joint press release announcing their combined fourth quarter 2025 earnings on January 29, 2026. The press release, furnished as Exhibit 99.1, includes both GAAP and non-GAAP financial measures.
The companies provide reconciliations from non-GAAP to the most directly comparable GAAP measures and explain why management believes these non-GAAP metrics are useful for understanding operating results. The earnings press release is furnished, not filed, meaning it is not automatically incorporated into other SEC filings.
Xerox Holdings Corporation has amended its shelf registration to increase the amount of securities it may offer, now allowing sales of up to $750,000,000 in common stock and warrants over time.
The company can issue these securities in one or more offerings, using underwriters, dealers, agents or direct sales, with specific terms and pricing detailed in future prospectus supplements. Net proceeds from any sale will be used as described in the applicable supplement. Xerox’s common stock is listed on the Nasdaq Global Select Market under the symbol XRX, and the last reported sales price on January 27, 2026 was $2.13 per share.
Xerox Holdings Corporation announced a warrant dividend distribution to holders of its common stock. Each shareholder of record on February 9, 2026 will receive warrants to purchase Xerox common stock, with distribution expected on or about February 11, 2026.
Holders of the company’s 3.75% Convertible Senior Notes due 2030 and Series A Convertible Perpetual Voting Preferred Stock as of the same record date will also receive warrants on equivalent terms, based on the applicable conversion rates. The company has filed a shelf registration statement on Form S-3 for the warrants and underlying stock and will file a prospectus describing their terms.